Cargando…

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Understanding the mechanism of chemoresistance and disease progression in patients with prostate cancer is important for developing novel treatment strategies. In particular, developing resistance to cabazitaxel is a major challenge in patients with docetaxel‐resistant and castration‐resistant prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natsagdorj, Ariunbold, Izumi, Kouji, Hiratsuka, Kaoru, Machioka, Kazuaki, Iwamoto, Hiroaki, Naito, Renato, Makino, Tomoyuki, Kadomoto, Suguru, Shigehara, Kazuyoshi, Kadono, Yoshifumi, Lin, Wen‐Jye, Maolake, Aerken, Mizokami, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317938/ https://www.ncbi.nlm.nih.gov/pubmed/30426599 http://dx.doi.org/10.1111/cas.13876

Ejemplares similares

Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis
por: Maolake, Aerken, et al.
Publicado: (2016)

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
por: Machioka, Kazuaki, et al.
Publicado: (2018)

Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
por: Maolake, Aerken, et al.
Publicado: (2018)

C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
por: Urata, Satoko, et al.
Publicado: (2018)

Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis
por: Kadomoto, Suguru, et al.
Publicado: (2019)

A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age
por: Iwamoto, Hiroaki, et al.
Publicado: (2020)

Reply to Comment on “Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020, 12, 89
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2015)

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20–CCR6 axis
por: Kano, Hiroshi, et al.
Publicado: (2022)

Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2023)

Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer
por: Kawaguchi, Shohei, et al.
Publicado: (2022)

Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Contribution of Retzius-sparing robot-assisted radical prostatectomy to the mechanism of urinary continence as demonstrated by dynamic MRI
por: Kadono, Yoshifumi, et al.
Publicado: (2023)

Investigating the mechanism underlying urinary continence using dynamic MRI after Retzius-sparing robot-assisted radical prostatectomy
por: Kadono, Yoshifumi, et al.
Publicado: (2022)

Carbon dioxide gas embolism during robot‐assisted laparoscopic partial nephrectomy
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic
por: Toriumi, Ren, et al.
Publicado: (2022)

Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

The CCL20-CCR6 Axis in Cancer Progression
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Three-dimensional morphological analysis of spermatogenesis in aged mouse testes
por: Nakano, Taito, et al.
Publicado: (2021)

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021)

Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Testosterone and Bone Health in Men: A Narrative Review
por: Shigehara, Kazuyoshi, et al.
Publicado: (2021)

Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2023)

Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy
por: Kadono, Yoshifumi, et al.
Publicado: (2022)

A case of adrenal lymphangioma resected laparoscopically with minimal invasiveness
por: Yaegashi, Hiroshi, et al.
Publicado: (2020)

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
por: Yoshida, Tsukasa, et al.
Publicado: (2022)

Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy
por: Shigehara, Kazuyoshi, et al.
Publicado: (2020)

Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels
por: Shigehara, Kazuyoshi, et al.
Publicado: (2023)

Relation between athletic club affiliation from school age and future serum free testosterone levels in Japan: A cross‐sectional study
por: Kato, Yuki, et al.
Publicado: (2023)

Epidemiology and Prevention of Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2022)

Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer
por: Toriumi, Ren, et al.
Publicado: (2022)

Androgen replacement therapy for cancer‐related symptoms in male: result of prospective randomized trial (ARTFORM study)
por: Izumi, Kouji, et al.
Publicado: (2021)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
por: Kitagawa, Yasuhide, et al.
Publicado: (2014)

Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients
por: IZUMI, KOUJI, et al.
Publicado: (2014)

Human papillomavirus 16–positive penile Bowen’s disease involving the distal urethra: A case report
por: Sakamoto, Jiro, et al.
Publicado: (2020)

Risk Factors Affecting Decreased Libido Among Middle-Aged to Elderly Men; Nocturnal Voiding is an Independent Risk Factor of Decreased Libido
por: Shigehara, Kazuyoshi, et al.
Publicado: (2021)

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL
por: Iwamoto, Hiroaki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sckdce8ijlc0kt50fep7ol8c94